One cheap ASX stock I'd buy before Westpac Banking Corp

Westpac Banking Corp (ASX:WBC) shares are offering a huge dividend, but over the long-term, ResMed Inc. (CHESS) (ASX:RMD) has proven to be a better investment.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Westpac Banking Corp (ASX: WBC) shares currently boast an enormous dividend yield of 6.2% – fully franked no less!

Grossed-up for those tax-effective franking credits, Westpac's dividend yield blows out to an incredible 8.8%.

By comparison, annual term deposits up to $250,000 at Westpac yield just 2.45%.

So with a forecast dividend yield roughly 3.5 times the expected return of term deposits, you might expect to see investors falling over themselves to buy shares in Australia's second largest bank. However, that's not what is happening.

In fact, Westpac shares are down more than 4% in the past month alone. In my opinion, it appears as though the market thinks the risk-reward trade-off for Westpac shares isn't worth its time.

1 blue chip stock I'd buy before Westpac

Indeed, there are bucket loads of companies listed on the ASX that I'd consider 'blue chip', and some of them I'd consider superior investments to Westpac at today's prices.

For example, earlier this month, I loaded up on more shares of ResMed Inc. (CHESS) (ASX: RMD).

ResMed is dually listed on the New York Stock Exchange and the ASX.

It is the global leader in the manufacture of devices for sufferers of sleep apnoea and related respiratory disorders.

While its forecast dividend yield of just 2.03% is far less spectacular when it's placed side-by-side to Westpac's 8.8%, the $10 billion company's total shareholder return (dividends plus capital gains) trumps that of Westpac shares.

Indeed, over the past 10 years, ResMed has achieved a compound annual total shareholder return of 11.6%, compared to Westpac's 9.9%, according to Morningstar.

Moreover, as the local economy slows, Westpac is likely to continue underperforming ResMed in my opinion. That's because ResMed will capitalise from ongoing increases in global healthcare spending, aging populations and a stronger global economy.

Buy, Hold or Sell?

Despite its huge dividend yield, I'd rate Westpac shares as a 'hold' — at best. Conversely, despite their low yield, ResMed shares appear far better long-term value at today's prices.

Motley Fool contributor Owen Raskiewicz owns shares of ResMed Inc.. Owen welcomes your feedback on Google plus (see below), LinkedIn or you can follow him on Twitter @ASXinvest. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »